Document:

Exhibit

Exhibit 10.14
 CONFIDENTIAL 

CONFIDENTIAL TREATMENT REQUESTED

CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. INFORMATION THAT WAS OMITTED IN THE EDGAR VERSION HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED BY THE MARK “[***]”. 

AMENDMENT NO. 1
TO SECOND AMENDED AND RESTATED NANTOMICS EXCLUSIVE RESELLER AGREEMENT

This Amendment No. 1 (the “Amendment”) is made as of the date of the last signature below and shall be effective as of October 1, 2017 (the “Amendment Effective Date”), by and between NantHealth, Inc. (“NantHealth”) and NantOmics, LLC (“NantOmics”).

RECITALS

Whereas, NantHealth and NantOmics are parties to that certain Second Amended and Restated NantOmics Exclusive Reseller Agreement, effective as of June 19, 2015 (the “Agreement”); 
 
Whereas, NantHealth and NantOmics wish to amend and clarify certain terms of the Agreement. 

Now, Therefore, the parties hereto, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, intending to be legally bound, agree as follows:

AGREEMENT

The Agreement is hereby amended as follows:

1.    In Section 3.1 of the Agreement (Revenue Share): 
		
	a.
	With respect to Omics Services completed between the Amendment Effective Date and June 30, 2018 (the “Fee Adjustment Period”): (i) the “Fee Floor” shall be [***] (instead of [***]) and (ii) the reference to “[***]” in the table in Section 3.1 shall be deemed to be “[***]”.

		
	b.
	In the last paragraph of Section 3.1, the phrase “if NantHealth bills” is hereby replaced with “if NantHealth bills following the Fee Adjustment Period”.

		
	2.
	Except as set forth in this Amendment, the Agreement is unaffected and shall continue in full force and effect in accordance with its terms. Except as otherwise modified or defined herein, all capitalized terms in this Amendment have the same meanings as set forth in the Agreement.  If there is conflict between this amendment and the Agreement or any earlier amendment, the terms of this Amendment will prevail.

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

IN WITNESS HEREOF, the parties have agreed and fully executed this Amendment.

NantHealth, Inc.                    NantOmics, LLC

By: /s/ Paul Holt                                                       By: /s/ Charles Kim                                            

Name: Paul Holt                                                       Name: Charles Kim                                            

Title: CFO                                                                 Title: eVP                                                            

Date: 12/18/2017                                                      Date: 12/18/2017                                                

[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.Exhibit

Exhibit 4.1

	
		
	NUMBER
	SHARES

	C-
	 

	 
	 

	SEE REVERSE FOR CERTAIN DEFINITIONS
	CUSIP 971375126

WILLSCOT CORPORATION
INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE
COMMON STOCK 
 
This Certifies that _______________is the owner of ______________fully paid and non-assessable shares of common stock of the par of the par value of $0.0001 each of WILLSCOT CORPORATION, a Delaware corporation (the “Company”), transferable on the books of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed.
 
This certificate is not valid unless countersigned by the Transfer Agent and registered by the Registrar.
 
	
			
	 
	 
	 

	Authorized Signatory
	 
	Transfer Agent 

1

Exhibit 4.1

WILLSCOT CORPORATION
 
The Company will furnish without charge to each shareholder who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class of shares or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights. This certificate and the shares represented thereby are issued and shall be held subject to all the provisions of the amended and restated memorandum and articles of association and all amendments thereto and resolutions of the Board of Directors providing for the issue of securities (copies of which may be obtained from the secretary of the Company), to all of which the holder of this certificate by acceptance hereof assents.
 
The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:
	
										
	TEN COM
	-
	as tenants in common
	 
	UNIF GIFT MIN ACT
	-
	 
	Custodian
	 
	 

	 
	 
	 
	 
	 
	 
	(Cust)
	 
	(Minor)
	 

	 
	 
	 
	 
	 
	 
	 
	 
	 
	 

	TEN ENT
	-
	as tenants by the entireties
	 
	 
	 
	Under Uniform Gifts to Minors Act

	 
	 
	 
	 
	 
	 
	 
	 
	 
	 

	 
	 
	 
	 
	 
	 
	 
	 
	 
	 

	JT TEN
	-
	as joint tenants with right of survivorship and not as tenants in common
	 
	 
	 
	(State)

Additional abbreviations may also be used though not in the above list. 
For value received,____________________ hereby sells, assigns and transfers unto ______________
 
(PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER(S) OF ASSIGNEE(S))
 
(PLEASE PRINT OR TYPEWRITE NAME(S) AND ADDRESS(ES), INCLUDING ZIP CODE, OF ASSIGNEE(S))
 
____________________________ Shares of the capital stock represented by the Certificate, and hereby irrevocably constitutes and appoints

___________________________ Attorney to transfer the said stock on the books of the within named Company with full power of substitution in the premises.
 
Dated ___________________
	
			
	 
	Notice:
	The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement or any change whatever.

	
		
	Signature(s) Guaranteed:
	 

	 

	THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE) UNDER THE SECURITIES ACT OF 1933, AS AMENDED).

2Exhibit

Exhibit 4.7

SUPPLEMENTAL INDENTURE
WILLIAM SCOTSMAN INTERNATIONAL, INC.
as Issuer 
and
THE GUARANTORS PARTY HERETO
----------------
7.875% SENIOR SECURED NOTES DUE 2022
----------------
SUPPLEMENTAL INDENTURE
DATED AS OF FEBRUARY 15, 2018
----------------
DEUTSCHE BANK TRUST COMPANY AMERICAS
as Trustee and Collateral Agent

Exhibit 4.7

This SUPPLEMENTAL INDENTURE, dated as of February 15, 2018, is by and among William Scotsman International, Inc. a Delaware corporation (the “Company”), each of the parties identified under the caption “Guarantors” on the signature page hereto (the “Guarantors”), Deutsche Bank Trust Company Americas, as trustee (in such capacity and not in its individual capacity, the “Trustee”) and Deutsche Bank Trust Company Americas, as collateral agent (in such capacity and not in its individual capacity, the “Collateral Agent”).
RECITALS
WHEREAS, the Company, the Trustee and the Collateral Agent entered into an Indenture, dated as of November 29, 2017 (the “Indenture”), pursuant to which the Company initially issued $300,000,000 in principal amount of 7.875% Senior Secured Notes due 2022 (the “Notes”).
WHEREAS, Section 9.1(9) of the Indenture provides that the Company, the Guarantors, the Trustee and the Collateral Agent may supplement the Indenture in order to add Guarantors pursuant to Sections 4.17 and 11.8 thereof, without the consent of the Holders; and
WHEREAS, all acts and procedures prescribed by the Indenture to make this Supplemental Indenture a legally valid and binding instrument on the Company, the Guarantors, the Trustee and the Collateral Agent, in accordance with its terms, have been duly done and performed;
NOW, THEREFORE, in compliance with the provisions of the Indenture and in consideration of the above premises, the Company, the Guarantors, the Trustee and the Collateral Agent covenant and agree for the equal and proportionate benefit of the respective Holders of the Notes as follows:
This Supplemental Indenture is supplemental to the Indenture and does and shall be deemed to form a part of, and shall be construed in connection with and as part of, the Indenture for any and all purposes.
This Supplemental Indenture shall become effective immediately upon its execution and delivery by each of the Company, the Guarantors, the Trustee and the Collateral Agent.
From this date, by executing this Supplemental Indenture, the Guarantors whose signatures appear below are subject to the provisions of the Indenture to the extent applicable.
Except as specifically modified herein, the Indenture and the Notes are in all respects ratified and confirmed (mutatis mutandis) and shall remain in full force and effect in accordance with their terms with all capitalized terms used herein without definition having the same respective meanings ascribed to them as in the Indenture.
Except as otherwise expressly provided herein, no duties, responsibilities or liabilities are assumed, or shall be construed to be assumed, by the Trustee or the Collateral Agent by reason of this Supplemental Indenture. This Supplemental Indenture is executed and accepted by the Trustee and the Collateral Agent subject to all the terms and conditions set forth in the Indenture with the same force and effect as if those terms and conditions were repeated at length herein and made applicable to the Trustee and the Collateral Agent with respect hereto.

Exhibit 4.7

No past, present or future director, officer, employee, incorporator, stockholder, partner, member or joint venturer of the Company or any Guarantor, as such, shall have any liability for any obligations of the Company or any Guarantor under the Notes, any Note Guarantees, the Indenture or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder of the Notes by accepting a Note waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes.
NEW YORK LAW TO GOVERN. THE INTERNAL LAW OF THE STATE OF NEW YORK SHALL GOVERN AND BE USED TO CONSTRUE THIS SUPPLEMENTAL INDENTURE.
The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of such executed copies together shall represent the same agreement. Delivery of an executed counterpart of a signature page to this Supplemental Indenture by telecopier, facsimile or other electronic transmission (i.e. “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart thereof.
[SIGNATURE PAGE FOLLOWS]

Exhibit 4.7

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first written above.
	
						
	 
	WILLIAMS SCOTSMAN INTERNATIONAL, INC.

	 
	 
	 
	 
	 

	 
	By:
	/s/ Timothy Boswell

	 
	 
	Name:
	Timothy Boswell

	 
	 
	Title:
	Chief Financial Officer

	 
	 
	 
	 
	 

	 
	ACTON MOBILE HOLDINGS, LLC

	 
	 
	 
	 
	 

	 
	By:
	/s/ Timothy Boswell

	 
	 
	Name:
	Timothy Boswell

	 
	 
	Title:
	Chief Financial Officer

	 
	 
	 
	 
	 

	 
	NEW ACTON MOBILE INDUSTRIES LLC

	 
	 
	 
	 
	 

	 
	By:
	/s/ Timothy Boswell

	 
	 
	Name:
	Timothy Boswell

	 
	 
	Title:
	Chief Financial Officer

	 
	 
	 
	 
	 

	 
	ONSITE SPACE LLC

	 
	 
	 
	 
	 

	 
	By:
	/s/ Timothy Boswell

	 
	 
	Name:
	Timothy Boswell

	 
	 
	Title:
	Chief Financial Officer

[Signature Page to Supplemental Indenture]

Exhibit 4.7

	
						
	 
	DEUTSCHE BANK TRUST COMPANY AMERICAS,

	 
	as Trustee

	 
	By:
	Deutsche Bank National Trust Company

	 
	 
	 
	 

	 
	By:
	/s/ Irina Golovashchuk

	 
	 
	Name:
	Irina Golovashchuk

	 
	 
	Title:
	Vice President

	 
	 
	 
	 
	 

	 
	By:
	/s/ Debra A. Schwalb

	 
	 
	Name:
	Debra A. Schwalb

	 
	 
	Title:
	Vice President

	 
	 
	 
	 
	 

	 
	 
	 
	 
	 

	 
	DEUTSCHE BANK TRUST COMPANY AMERICAS,

	 
	as Collateral Agent

	 
	By:
	Deutsche Bank National Trust Company

	 
	 
	 
	 

	 
	By:
	/s/ Irina Golovashchuk

	 
	 
	Name:
	Irina Golovashchuk

	 
	 
	 
	 
	 

	 
	By:
	/s/ Debra A. Schwalb

	 
	 
	Name:
	Debra A. Schwalb

	 
	 
	Title:
	Vice President

[Signature Page to Supplemental Indenture]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]